Bladder-sparing approaches to invasive disease (Q36643625)

15 August 2017

1 reference

title

Bladder-sparing approaches to invasive disease (English)

1 reference

15 August 2017

1 reference

Jason A Efstathiou

1

1 reference

15 August 2017

Anthony L Zietman

2

1 reference

15 August 2017

Donald S Kaufman

3

1 reference

15 August 2017

Niall M Heney

4

1 reference

15 August 2017

John J Coen

5

1 reference

15 August 2017

William U Shipley

6

1 reference

15 August 2017

1 November 2006

1 reference

15 August 2017

World Journal of Urology

1 reference

15 August 2017

24

1 reference

15 August 2017

517-529

1 reference

15 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s00345-006-0114-y

15 August 2017

0 references

cites work

The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on

1 reference

12 December 2020

Effective bladder sparing therapy with intra-arterial cisplatin and radiotherapy for localized bladder cancer

1 reference

12 December 2020

Local recurrence after cystectomy alone for bladder carcinoma

1 reference

12 December 2020

Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer.

1 reference

12 December 2020

Preliminary results in invasive bladder cancer with transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy

1 reference

12 December 2020

Quality of life assessment after concurrent chemoradiation for invasive bladder cancer: results of a multicenter prospective study (GETUG 97-015).

1 reference

12 December 2020

Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. A survey by a self-administered questionnaire

1 reference

12 December 2020

Treatment of invasive bladder cancer by local resection and high dose methotrexate

1 reference

12 December 2020

p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.

1 reference

12 December 2020

Radical cystectomy with or without prior irradiation in the treatment of bladder cancer

1 reference

12 December 2020

A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer

1 reference

12 December 2020

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results

1 reference

12 December 2020

A critical analysis of perioperative mortality from radical cystectomy.

1 reference

12 December 2020

Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer

1 reference

12 December 2020

Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy

1 reference

12 December 2020

Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy

1 reference

12 December 2020

Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based

1 reference

12 December 2020

Conservative management of muscle-infiltrating bladder cancer: prospective experience.

1 reference

12 December 2020

Organ preservation in patients with invasive bladder cancer: initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil

1 reference

12 December 2020

Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population.

1 reference

12 December 2020

Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12

1 reference

12 December 2020

Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?

1 reference

12 December 2020

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time.

1 reference

12 December 2020

Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group.

1 reference

12 December 2020

1 reference

12 December 2020

Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder

1 reference

12 December 2020

Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch

1 reference

12 December 2020

Influence of bladder and rectal volume on spatial variability of a bladder tumor during radical radiotherapy.

1 reference

12 December 2020

Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome

1 reference

12 December 2020

Overview of bladder cancer trials in the European Organization for Research and Treatment

1 reference

12 December 2020

Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report

1 reference

12 December 2020

Comparison of transurethral resection to radical therapies for stage B bladder tumors

1 reference

12 December 2020

Radiotherapy for stage T3b transitional cell carcinoma of the bladder

1 reference

12 December 2020

Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer

1 reference

12 December 2020

Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study

1 reference

12 December 2020

Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy

1 reference

12 December 2020

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

1 reference

12 December 2020

Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer

1 reference

12 December 2020

The quality of life after radical radiotherapy for bladder cancer

1 reference

12 December 2020

Complications of radical cystectomy for nonmuscle invasive disease: comparison with muscle invasive disease

1 reference

12 December 2020

Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery

1 reference

12 December 2020

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

12 December 2020

Selective bladder preservation by combination treatment of invasive bladder cancer

1 reference

12 December 2020

Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: an Eastern Cooperative Oncology Group Study

1 reference

12 December 2020

Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis

1 reference

12 December 2020

The role of paclitaxel in the therapy of bladder cancer.

1 reference

12 December 2020

Urinary diversion: ileal conduit to neobladder

1 reference

12 December 2020

Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era

1 reference

12 December 2020

Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers.

1 reference

12 December 2020

Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study

1 reference

12 December 2020

Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy

1 reference

12 December 2020

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

1 reference

12 December 2020

Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?

1 reference

12 December 2020

Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors

1 reference

12 December 2020

Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification

1 reference

12 December 2020

Adaptive radiotherapy for invasive bladder cancer: a feasibility study.

1 reference

12 December 2020

Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone

1 reference

12 December 2020

Cystectomy for bladder cancer: a contemporary series

1 reference

12 December 2020

Distressful symptoms after radical radiotherapy for urinary bladder cancer.

1 reference

12 December 2020

Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial

1 reference

12 December 2020

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03

1 reference

12 December 2020

Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder

1 reference

12 December 2020

Treatment of advanced bladder cancer category T2 T3 and T4a. A randomized multicenter study of preoperative irradiation and cystectomy versus radical irradiation and early salvage cystectomy for residual tumor. DAVECA protocol 8201. Danish Vesical C

1 reference

12 December 2020

Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: a long-term follow-up of 276 consecutive patients

1 reference

12 December 2020

Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer

1 reference

12 December 2020

Combined modality treatment with selective bladder conservation for invasive bladder cancer: long-term tolerance in the female patient.

1 reference

12 December 2020

Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802

1 reference

12 December 2020

4,000 RAD preoperative irradiation followed by prompt radical cystectomy for invasive bladder carcinoma: a prospective study of patient tolerance and pathologic downstaging

1 reference

12 December 2020

Bladder cancer.Superiority of preoperative irradiation and cystectomy in clinical stages B2 and C

1 reference

12 December 2020

10.1007/S00345-006-0114-Y

Identifiers

DOI

1 reference

15 August 2017

1 reference